Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Nephrology

Renal Failure Clinical Trials

A listing of Renal Failure medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Phoenix Arizona 85012

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Tucson Arizona 85745

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

California

University of California, San Francisco
San Francisco California 94143

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

UPDATED

Fresno California 93710

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Long Beach California 90822

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Mather California 95655

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

San Diego California 92123

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Florida

UPDATED

Tampa Florida 33606

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Illinois

UPDATED

Alsip Illinois 60803

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Maryland

University of Maryland School of Medicine
Baltimore Maryland 21201

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

UPDATED

Easton Maryland 21601

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Massachusetts

Massachussetts General Hospital
Boston Massachusetts 02114

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

UPDATED

Boston Massachusetts 02115

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Boston Massachusetts 02114

A Phase 4 clinical study for patients with Renal Failure

Michigan

UPDATED

Flint Michigan 48507

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Mississippi

UPDATED

Greenwood Mississippi 38930

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Missouri

UPDATED

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

New Jersey

UPDATED

Newark New Jersey 07103

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Westfield New Jersey 07090

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

New York

The Rogosin Institute - New York Presbyterian
New York New York 10021

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

Oregon

UPDATED

Portland Oregon 97201

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Pennsylvania

University of Pennsylvania
Philadelphia Pennsylvania 19104

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

Hershey Pennsylvania 17033

A clinical trial for patients with Immunosuppression or Renal Failure

South Carolina

UPDATED

Orangeburg South Carolina 29118

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Texas

UPDATED

Dallas Texas 75226

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Wisconsin

University of Wisconsin
Madison Wisconsin 53792

Research Study of ATG and Rituximab in Renal Transplantation (RESTARRT)

View More ▼

UPDATED

Madison Wisconsin 53706

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Madison Wisconsin 53792

Patients are needed to participate in a clinical research study evaluating 62Cu-ethylglyoxal bis(thiosemicarbazone), 15O-water and Positron Emission Tomography for the treatment of Renal Failure or Renal Artery Stenosis

Israel

UPDATED

Hadera Haifa 38100

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Haifa 3109601

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Jerusalem 9103102

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Ramat Gan Tel-Aviv 52621

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Tzrifin 70300

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Poland

UPDATED

Lublin Lubelskie 20-081

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Warszawa 02-097

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Wroclaw 51-124

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Switzerland

Biel/Bienne 2501

A clinical trial to evaluate treatments for patients with Hypoosmolality, Hyperosmolality or Renal Failure

United Kingdom

Bangor

Patients are needed to participate in a clinical research study evaluating Automatic RR Measurement

UPDATED

Birmingham West Midlands B15 2TH

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Glasgow G51 4TF

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Leeds LS1 3EX

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

UPDATED

Leicester East Midlands/ Leicestershire LE5 4PW

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

View More ▼

UPDATED

London Greater London SE1 9RT

A clinical trial to evaluate treatments using Human Acellular Vessel (HAV) and ePTFE graft for patients with Renal Failure, End Stage Renal Disease, Hemodialysis or Vascular Access

Oxford OX3 7LE

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Portsmouth

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Surrey

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure

Swindon

Patients are needed to participate in a clinical research study of Bortezomib, Thalidomide, Bendamustine and Dexamethasone to evaluate Multiple Myeloma, Chronic Kidney Disease, or Myeloma Renal Failure